Side Letters and Side Agreements: How Quiet Investor Accommodations Become Series B Diligence Landmines

A side letter is a bilateral agreement between a company and one specific investor that sits alongside the main financing documents. It grants that investor rights, economics, or accommodations that other investors in the same round do not receive. At seed and Series A, side letters are common and often look routine. At Series B, they become a diligence problem if they were never disclosed, tracked, or mapped against the rights the new lead investor expects to find in the main documents.

The biggest risk is not the clause itself. It is the discovery moment. When a Series B lead finds an off-document agreement that contradicts or expands the rights shown in the cap table summary or investor rights agreement, the question is no longer about that one clause. The question becomes whether there are other agreements the company did not surface. That credibility problem can stall a process, reprice a term sheet, or end the conversation. This is one of the most common structural issues covered in what cap table problems kill a Series B before the lead investor reads your deck.

Key takeaways:

• Side letters that grant MFN rights, expanded pro rata, enhanced information rights, board observer seats, transfer exemptions, or governance veto carve-outs create off-document rights that a new lead cannot fully model until diligence
• Undisclosed side letters do not just create legal complexity. They signal cap table governance problems
• The median number of obligations in side letters rose 33% from 2021 to 2024, reaching 20 per agreement, according to Ontra's side letter research
• Every side letter right that conflicts with the proposed Series B term sheet requires a waiver, amendment, or consent before closing
• The time to disclose and clean up side letter rights is before outreach begins, not after a term sheet is signed

What Side Letters Actually Grant

Side letters can cover a wide range of investor-specific accommodations. Most fall into six categories. Each one is manageable when disclosed and tracked. Each one becomes a diligence problem when it sits off the record.

The NVCA model financing documents are designed so that investor rights, transfer restrictions, and voting mechanics are harmonized across the investor rights agreement, voting agreement, and ROFR and co-sale agreement. When any of these rights live instead in a side letter, a new lead investor cannot see them by reviewing the main document set alone. That gap is where diligence friction starts.

Why Undisclosed Side Letters Become a Series B Credibility Problem

Most founders think the risk is the clause. The real risk is the sequence of events that follows discovery.

The Discovery Sequence

1. The lead investor's outside counsel opens the data room. They review the investor rights agreement, voting agreement, and ROFR and co-sale agreement. The rights matrix looks clean.
2. A side letter surfaces. It may appear in a folder the company included without flagging, or it may emerge during a document request. The clause itself might be minor. But it is not in any main document.
3. Outside counsel flags the discrepancy. The lead investor now knows there is at least one off-document agreement. They ask whether there are others. The company has to confirm or produce a full side letter inventory it may not have prepared.
4. The IC conversation shifts. The lead's investment committee is no longer evaluating a clean cap table. They are evaluating a cap table that required a mid-diligence correction. That change in framing affects how they underwrite everything else they read.
5. Waiver and amendment requests go out. Each one adds legal cost, negotiation time, and the possibility that an investor declines to cooperate.

"Diligence reveals undisclosed terms, forcing disclosure and potentially halting deals due to misrepresentation concerns." — Proskauer legal commentary on side letter discovery risk

The credibility loss from this sequence is often worse than the clause itself. A single undisclosed MFN provision is a legal fix. A company that did not know its own side letter inventory is a governance problem. Series B investors are buying into a management team as much as a cap table. Cap table discipline is part of the evaluation.

The Four Side Letter Provisions That Cause the Most Diligence Damage

Not all side letter rights create equal friction. These four show up most often in Series B diligence problems.

• MFN clauses that silently reset economics. According to Kruze Consulting's analysis of side letter mechanics, MFN clauses appear in roughly 58% of side letters. The problem is drafting ambiguity. MFN provisions often turn on "similarly situated" language or commitment-size qualifiers. When those terms are vague, an investor may have a reasonable claim to elect rights the company never intended to extend. A Series B lead who finds an MFN clause with unclear scope cannot model the full rights picture until counsel works through every prior side letter. That analysis takes time and creates uncertainty.
• Expanded pro rata rights that conflict with the lead's allocation model. Standard pro rata rights live in the investor rights agreement and apply to the full class. A side letter that grants one investor a larger or differently structured pro rata right can directly conflict with the lead's planned ownership stake. If the lead needs to take a 20% position and a prior investor has a side letter right to participate at a level that compresses that, the round math changes before terms are finalized.
• Enhanced information rights and observer seats that create asymmetry. When one investor receives more detailed or more frequent financial reporting than others, the company is managing parallel disclosure obligations. For a Series B lead, this raises questions about confidentiality, board governance, and whether the observer will have access to sensitive pre-announcement information. The Hidden Cost of Uncapped MFN SAFEs covers how off-document economic rights from seed instruments stack into Series B modeling problems in similar ways.
• Transfer exemptions that bypass ROFR and co-sale mechanics. If a prior investor received a side letter exemption from the ROFR and co-sale agreement for affiliate transfers, shares may have moved in the cap table without triggering the standard consent process. A new lead reviewing the cap table may find holders they did not expect, or find that the ROFR mechanics they are relying on have been partially carved out.

The four provisions above share one trait: they are not visible in the main financing documents. A Series B lead reviewing the IRA, voting agreement, and ROFR and co-sale agreement will not find them. They only appear when someone asks the right question or opens the right folder.

How Side Letter Conflicts Compound When a New Term Sheet Arrives

When a Series B lead issues a term sheet, they are working from an assumption: that the main financing documents reflect the full economic and governance picture of the company.

Side letters that expand or contradict those documents break that assumption. Each one requires a resolution before closing.

• A side letter MFN clause may require the company to offer the same Series B economics to a prior investor who holds election rights
• An expanded pro rata right may require the company to carve out allocation that the lead expected to control
• An observer seat that was not disclosed may require the lead to agree to governance terms they did not expect
• A transfer exemption that bypassed ROFR may require the company to retroactively address cap table movement before the new round can close

Each of these is solvable. But each one adds outside counsel time, negotiation rounds, and closing risk. When multiple side letters surface at once, the cumulative effect is a financing that looks harder to close than the lead anticipated. That perception affects price and conviction.

The same dynamic applies when advisors, contractors, or strategic partners hold equity with side arrangements attached. The equity grants to advisors and contractors guide covers how those off-document arrangements create similar cap table pollution before a Series B. The underlying problem is the same: rights that a new lead cannot see in the main documents until diligence forces them into view.

What to Disclose and Fix Before You Go to Market

The goal is to control when and how side letter rights are disclosed. Discovery on your timeline, before outreach begins, is a legal and administrative task. Discovery during opposing counsel review is a credibility event.

Pre-Process Side Letter Checklist

• Build a complete inventory. Pull every side letter executed alongside equity rounds, SAFEs, convertible notes, and any transfer or observer arrangements. Include informal email confirmations that may have created binding commitments.
• Map each right against the main documents. Compare every side letter grant against the investor rights agreement, voting agreement, ROFR and co-sale agreement, and cap table model. Flag any provision that expands, contradicts, or sits outside those documents.
• Identify conflicts with the proposed Series B terms. Before outreach begins, run the side letter inventory against the term sheet economics and governance structure you plan to propose. Any conflict is a waiver or amendment target.
• Pursue waivers and amendments before launch. Investors who are asked to waive a side letter right before a process starts are in a cooperative posture. Investors who are asked mid-diligence are in a negotiating posture.
• Prepare a side letter disclosure schedule for the data room. Every side letter should be indexed, summarized, and included in the data room before the first investor opens it. This is the same discipline that applies to uncapped convertible note overhang, where off-document complexity discovered mid-diligence creates the same credibility friction.
• Confirm your cap table software reflects the full picture. If side letter rights affect allocation, transfer, or conversion mechanics, those effects need to appear in the fully diluted cap table model before the data room opens.

The IRC Partners side letter overview for real estate fund LPAs covers how the same MFN cascade and disclosure discipline applies in institutional fund structures, where the consequences of unmanaged side letter rights are equally serious.

Compile a complete side letter inventory before you launch a Series B process or enter any liquidity event. Map every grant against your main financing documents, identify conflicts with your proposed term sheet, and prepare a disclosure schedule for the data room. A new lead investor who finds an undisclosed side agreement mid-diligence does not see a drafting oversight. They see a cap table they cannot fully trust.

Frequently Asked Questions‍

What actually triggers an MFN clause in a venture side letter?

An MFN clause is triggered when the company grants another investor more favorable terms than the MFN holder currently has. The MFN holder then has an election right, typically exercisable within 30 to 60 days of receiving the other investor's side letter, to adopt those better terms. According to Morgan Lewis's fund formation deskbook, the scope of what qualifies as "more favorable" often depends on whether the other investor is deemed "similarly situated," which is a common source of dispute when the drafting is vague.

Do side letters automatically survive a new financing round?

Not automatically. Whether a side letter survives a new round depends on its own terms and whether it is superseded by the new financing documents. Some side letters include explicit survival language. Others are silent on the question, which creates ambiguity. When a Series B closes with new investor rights and voting agreements, counsel should confirm whether prior side letter rights are superseded, amended, or carried forward.

Can a side letter override the main investor rights agreement?

A side letter can supplement or modify the IRA for the specific investor who is a party to it, but it cannot override provisions that require approval from the full investor class or the board. Provisions that conflict with the IRA's core terms are generally unenforceable unless the IRA itself permits the modification. This is why side letters that expand information rights or pro rata rights beyond the IRA baseline create ambiguity rather than clean contractual authority.

What happens when a side letter conflicts with a new Series B term sheet?

The conflict has to be resolved before closing. Resolution typically requires one of three things: a waiver from the side letter holder, an amendment to the side letter, or a modification to the Series B terms. Each path requires negotiation and legal work. If the side letter holder is uncooperative or the conflict is material, it can delay the closing or change the economics of the deal.

Can a company ask an existing investor to waive side letter rights?

Yes, but the investor has no obligation to agree. Waiver requests are easier when made before a process starts, when the investor is cooperative, and when the company can offer something in return. Investors who are asked to waive rights mid-diligence, under time pressure, are in a stronger negotiating position. This is why pre-process cleanup matters.

How does information rights asymmetry affect Series B diligence?

When one investor receives more detailed financial reporting than others, the Series B lead has to assess whether that reporting obligation creates confidentiality risk, whether it will continue post-closing, and whether the lead's own information rights package will be at least as strong. If the side letter information rights are broader than what the lead expects to receive, that creates a governance conversation the company has to manage before the round closes.

How should a side letter disclosure schedule be structured for a data room?

The disclosure schedule should list every side letter by investor name, execution date, and round. For each one, it should summarize the key grants in plain language, identify whether any grants conflict with the main financing documents, and note the status of any waiver or amendment efforts. The schedule should be placed in the legal section of the data room alongside the main financing documents, not buried in a miscellaneous folder. Investors who find it organized and complete read it as a sign of cap table discipline.

Continue reading this series:

• What Cap Table Issues Will Kill a Series B Before the Lead Investor Even Reads Your Deck
• The Hidden Cost of Uncapped MFN SAFEs: How Most-Favored-Nation Clauses Silently Reprice Your Entire Seed Round at Series B
• How Equity Grants to Advisors, Contractors, and Strategic Partners Quietly Pollute Your Cap Table Before Series B

Most founders don't lose the raise because of the pitch. They lose it because the structure was wrong before the first investor call. IRC Partners advises founders raising $5M to $250M of institutional capital. 7 strategic partners per quarter. Start here to schedule a call with our team.